Al Dente and Labelium Group announce joint strategic venture to fuel a new era of success for luxury brands
LT Capital has sold its stake in Al Dente to Labelium Group with the support of Charterhouse Capital Partners LLP, a UK private equity fund.
Founded in 2004, Al Dente is an international new-generation creative agency that draws on the culture of luxury brands, providing modernity and inspiration to future generations while protecting its DNA. From brand strategy to positioning and branding at large, the company conceptualizes storytelling and adopts a 360° approach to building business relationships with its clients. Al Dente has solid expertise in executing campaigns on all types of digital and traditional media as well as a clear understanding of the luxury industry codes and the cultural aura of luxury brands. Its integration of the value chain with two in-house studios is perfectly adapted to the latest developments in the image world, providing a high level of reactivity and flexibility while preserving the creative momentum. Al Dente has a unique positioning in the market and benefits from significant growth dynamics: the digitalization of the luxury sector. The agency has demonstrated its ability to generate strong organic growth, relying on an historic and loyal client base composed of luxury brands, such as Boucheron, Pucci, Chopard, LVMH and Baccarat.
Labelium Group is a global, independent digital marketing consultancy that specializes in accelerating client growth through data-driven marketing strategies. With expertise across a range of digital channels, platforms and networks, the firm enables brands across all sectors, such as Sephora, L'Oréal and SFR, to maximize their online potential and effectively reach their target audiences. Having a network of 23 offices in 16 countries, Labelium provides a broad spectrum of services, from strategy consulting to day-to-day execution through to project and data management, in four main areas: media performance, retail performance, digital intelligence and strategy consulting. Since the Charterhouse fund invested in the group in 2021, Labelium has made a half-dozen acquisitions, operating a global buy-and-build platform.
LT Capital is a French private equity firm headquartered in Paris. It provides equity capital to fast-growing SMEs and supports entrepreneurs in their growth projects in France and abroad while adopting an environmental, societal and balanced governance approach. With more than 20 years of experience, LT Capital has supported 49 companies across several sectors, with tickets between US$3.2 million and US$16 million.
Oaklins’ team in France supported Al Dente for the second time in its joint strategic venture with Labelium Group. The team shortlisted a number of potential acquirors and identified Labelium Group as the best candidate to accelerate Al Dente’s growth and development project, while directly benefiting from the combined services to offer comprehensive solutions to its luxury clients.
Patrizio Miceli
President, Al Dente
Sprechen Sie mit dem Deal-Team
Transaktionen
Scholarcy Limited has been acquired by Texthelp Group
Texthelp Group, a global provider of digital tools for inclusive learning and working, has acquired Scholarcy Limited. This acquisition marks a significant step towards fulfilling Texthelp’s vision of improving the literacy and understanding of one billion people by 2030.
Mehr erfahrenPBV Investment Holding Europe-America, S.L. (IDP Group) has been sold to Bureau Veritas
Nazca Capital and the company founders have sold PBV Investment Holding Europe-America, S.L. (IDP Group) to Bureau Veritas. This strategic acquisition will allow Bureau Veritas to expand its leadership in building and infrastructure solutions and meet sustainability challenges through IDP’s digital portfolio assets.
Mehr erfahrenHD Clinical Ltd. has been acquired by NEXUS AG
NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.
Mehr erfahren